Literature DB >> 18410353

Tuberculosis-HIV co-infection: policy and epidemiology in 25 countries in the WHO European region.

J V Lazarus1, M Olsen, L Ditiu, S Matic.   

Abstract

OBJECTIVES: The aims of this study were to collect and review tuberculosis (TB)-HIV data for Europe and to provide an overview of current health policies addressing co-infection.
METHODS: We collected reported cases of TB-HIV from the 25 most affected member states of the World Health Organization (WHO) European region. Countries were also asked whether they had implemented health policies covering collaborative TB-HIV activities and what their main achievements, obstacles and needs were in addressing TB-HIV.
RESULTS: Twenty countries reported registering a total of 6925 TB-HIV cases in 2005. Among TB patients tested, 3.3% were found to be HIV-positive, up from 2.1% in 2004. The male-to-female ratio was 2.7:1. The largest percentage of co-infections were reported in people aged 25-34 years (47.8%). Recommended TB-HIV policies have been implemented in many of the countries.
CONCLUSIONS: Case-finding has improved in many countries and the reported incidence of TB-HIV is increasing in the European region, particularly among young adults, although it remains low compared to other parts of the world. Strengthened coordination of existing TB and HIV services is still needed.

Entities:  

Mesh:

Year:  2008        PMID: 18410353     DOI: 10.1111/j.1468-1293.2008.00567.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  15 in total

1.  Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?

Authors:  S D Lawn; A D Harries; B G Williams; R E Chaisson; E Losina; K M De Cock; R Wood
Journal:  Int J Tuberc Lung Dis       Date:  2011-05       Impact factor: 2.373

2.  Modeling the dynamic relationship between HIV and the risk of drug-resistant tuberculosis.

Authors:  Rinat Sergeev; Caroline Colijn; Megan Murray; Ted Cohen
Journal:  Sci Transl Med       Date:  2012-05-23       Impact factor: 17.956

3.  Immunogenicity and protective efficacy of recombinant Bacille Calmette-Guerin strains expressing mycobacterium antigens Ag85A, CFP10, ESAT-6, GM-CSF and IL-12p70.

Authors:  Fu-Ying Dai; Jun-Fang Wang; Xue-Li Gong; Lang Bao
Journal:  Hum Vaccin Immunother       Date:  2017-02-14       Impact factor: 3.452

4.  Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across Europe.

Authors:  M Mansfeld; A Skrahina; L Shepherd; A Schultze; A M Panteleev; R F Miller; J M Miro; I Zeltina; S Tetradov; H Furrer; O Kirk; A Grzeszczuk; N Bolokadze; A Matteelli; F A Post; J D Lundgren; A Mocroft; Amw Efsen; D N Podlekareva
Journal:  HIV Med       Date:  2015-05-11       Impact factor: 3.180

5.  Health-Related Quality of Life and Associated Factors Among Adult HIV Mono-Infected and TB/HIV Co-Infected Patients in Public Health Facilities in Northeast Ethiopia: A Comparative Cross-Sectional Study.

Authors:  Tilahun Hailu; Mezgebu Yitayal; Lake Yazachew
Journal:  Patient Prefer Adherence       Date:  2020-10-12       Impact factor: 2.711

Review 6.  Epidemiology of HIV-associated tuberculosis.

Authors:  Stephen D Lawn; Gavin Churchyard
Journal:  Curr Opin HIV AIDS       Date:  2009-07       Impact factor: 4.283

7.  HIV-prevalence in tuberculosis patients in Germany, 2002-2009: an estimation based on HIV and tuberculosis surveillance data.

Authors:  Lena Fiebig; Christian Kollan; Barbara Hauer; Barbara Gunsenheimer-Bartmeyer; Matthias An der Heiden; Osamah Hamouda; Walter Haas
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

8.  First Outcome of MDR-TB among Co-Infected HIV/TB Patients from South-West Iran.

Authors:  Mohammad Motamedifar; Hadi Sedigh Ebrahim-Saraie; Ali Reza Hassan Abadi; Mahboube Nakhzari Moghadam
Journal:  Tuberc Respir Dis (Seoul)       Date:  2015-06-30

9.  Clinical presentation, demographics and outcome of tuberculosis (TB) in a low incidence area: a 4-year study in Geneva, Switzerland.

Authors:  Omar Kherad; François R Herrmann; Jean-Pierre Zellweger; Thierry Rochat; Jean-Paul Janssens
Journal:  BMC Infect Dis       Date:  2009-12-31       Impact factor: 3.090

10.  Prevalence and Factors Associated with Tuberculosis Treatment Success among TB/HIV Co-Infection in North-East Malaysia.

Authors:  Tengku Mardhiah Tengku Jalal; Sarimah Abdullah; Farhanah Abd Wahab; Sharina Dir; Nyi Nyi Naing
Journal:  Malays J Med Sci       Date:  2017-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.